Association for the Promotion of Quality Control in Medical Biology
| IQC 2024 - Hemostasis (HMPE) |
|---|
|
Expert Biologists - Scheme Coordinators:
Chantal Bon and Roland Meley IQC performed since 1975
Number of participating laboratories in 2023: 37 |
1 – Scheme overview
ATTENTION ! This program will not be renewed for the year 2025. Ordering of control products possible until the end of March 2025 at the latest.
This internal quality control scheme is intended to monitor the trueness and intermediary repeatability of the most common hemostasis tests.
The target values and acceptable limits for each peer group are defined based on the previous year’s EQA schemes provided at the beginning of the scheme (target values are set by the results of 630 laboratories).
Control samples are CE marked in accordance with European directive 98/79 EC and French law.
2 levels of assessment are provided for all the analytes tested:
| Analyzes | Level 1 :
Normal level |
Level 2 :
Disease-related level |
| Prothrombin time (in seconds, % and INR) | 70 to 100% | 30 to 50% |
| Activated Partial Thromboplastin Time (aPTT), PTTK | <40 seconds | 50 to 70 seconds |
| Fibrinogen | 2.5 to 3.5 g/L | 1.0 to 1.5 g/L |
| Antithrombin | 80 to 130% | 30 to 60% |
| PT factors (II, V, VII and X) | 70 to 125% | 30 to 60% |
| aPTT factors (VIII, IX, XI and XII) | 70 to 125% | 30 to 60% |
| Protein C, Protein S and Free Protein S | 70 to 130% | 30 to 60% |
Samples are provided in kits of 24 vials, which once resuspended, contain 1 mL.
2 – List of analytes assessed
3 – Description of the control samples
Lyophilized human plasma (citrate) (samples to be resuspended in 1 mL of distilled water).
IQC expiry date - Hemostasis 2024: 2025-06
4 – Storage of reconstituted samples
| | Confidentiality Policy | General Terms of Sale | | Last updated : 04/09/2023 | Copyright © 2011-2023 ProBioQual All rights reserved. |